Andrew Xu is the founder of Worg Pharmaceuticals. Worg Pharmaceuticals has raised $243M in total funding. Latest round: Series D. Based in Shanghai, China.
Andrew Xu is the Chairman & CEO of Worg Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing new treatments for allergies and other diseases. He has over 25 years of industrial experience, with expertise in business development, organizational transformation, global business operations, and corporate M&A. Previously, he served as President and Vice Chairman of PORTON Pharmaceutical, where he led the company through equity reforms and an IPO, and oversaw international acquisitions.
Full founder directory · Investor directory · Company funding database · Fundraising library